Effect of nicorandil on coronary events in patients with stable angina: The Impact Of Nicorandil in Angina (IONA) randomised trial

Lancet

Volumn 359, Issue 9314, 2002, Pages 1269-1275

  Dargie, H J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT; INSULIN; NICORANDIL; NITRIC ACID DERIVATIVE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEADACHE; HEART INFARCTION; HEART PROTECTION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; THORAX PAIN; TREATMENT OUTCOME;

EID: 0037070736     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08265-X     Document Type: Article

References (32)

1. Angina pectoris: Epidemiology and risk factors
2. Clinical epidemiology of coronary heart disease in the UK
3. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival study (4S)
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
6. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol
7. Comparison of acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate
8. Acute hemodynamic effects of nicorandil in coronary artery disease
9. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: An overview
10. Nicorandil as a hybrid between nitrates and potassium channel activators
11. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: Results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients
12. A double-blind comparison of nicorandil and metoprolol in patients with effort stable angina
13. Comparison of the antiischaemic and antianginal effect of nicorandil and amlodipine in patients with symptomatic stable angina pectoris: The SWAN study
14. Preconditioning with ischaemia: A delay of lethal cell injury in ischaemic myocardium
15. Cardioprotection by opening of the KATP channel in unstable angina
16. Mechanisms of cardiac pain during coronary angioplasty
17. Preconditioning the human myocardium
18. Ischaemic preconditioning reduces Troponin T release in patients undergoing coronary bypass surgery
19. Impact of Nicorandil in Angina (IONA): Design, methodology, and management
20. Unstable angina: An etiologic approach to management
21. Nicorandil attenuates myocardial dysfunction associated with transient ischaemia by opening ATP dependent potassium channels
22. Role of ATP dependent potassium channels in myocardial ischaemia
23. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels
24. A comparison of hydralazine/isosorbide dinitrate in the treatment of chronic congestive heart failure
25. Antiischemic effects of nicorandil during coronary angioplasty in humans
26. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease
27. Angina reassessed: Pain or protector
28. Effects of treatment on outcome in mildly symptomatic patients with ischaemia during daily life: The Atenelol Silent Ischaemia study (ASIST)
29. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study
30. Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome
31. Effects of metoprolol vs verapamil in patients with stable angina: The Angina Prognosis study in Stockholm